Do you want to read an article? Please log in or register.
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant
Atrial Fibrillation
Related content
Atrial Fibrillation
Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation
J Am Coll Cardiol.
Osmancik P, Herman D, Neuzil P, Hala P, Taborsky M, Kala P, Poloczek M, Stasek J, Haman L, Branny M, Chovancik J, Cervinka P, Holy J, Kovarnik T, Zemanek D, Havranek S, Vancura V, Opatrny J, Peichl P, Tousek P, Lekesova V, Jarkovsky J, Novackova M, Benesova K, Widimsky P, Reddy VY, PRAGUE-17 Trial Investigators.
doi: 10.1016/j.jacc.2020.04.067.
COMMENTED
Atrial Fibrillation
Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants
★ 2
Recommended and commented by
Prof. Dr Sacha P. Salzberg, Faculty Member
J Am Coll Cardiol
Camm AJ, Cools F, Virdone S, Bassand JP, Fitzmaurice DA, Arthur Fox KA, Goldhaber SZ, Goto S, Haas S, Mantovani LG, Kayani G, Grierson Turpie AG, Antoon Verheugt FW, Kakkar AK, GARFIELD-AF Investigators.
doi: 10.1016/j.jacc.2020.07.045
Atrial FibrillationHeart, Artery and Coronary Diseases
The Efficacy and Safety of the Use of Non-Vitamin-K Antagonist Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials
Circulation.
Bennaghmouch N, de Veer AJWM, Bode K, Mahmoodi BK, Dewilde WJM, Lip GYH, Brueckmann M, Kleine E, Ten Berg JM
doi: 10.1161/CIRCULATIONAHA.
Atrial Fibrillation
Direct Current Cardioversion of Atrial Fibrillation in Patients With Left Atrial Appendage Occlusion Devices
J Am Coll Cardiol.
Sharma SP, Turagam MK, Gopinathannair R, Reddy V, Kar S, Mohanty S, Cheng J, Holmes DR Jr, Sondergaard L, Natale A, Lakkireddy D
doi: 10.1016/j.jacc.2019.08.1045.Visit the original publication at ncbi.nlm.nih.gov
Atrial FibrillationThrombosis and Stroke
Laboratory Monitoring of Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation: A Review
JAMA Cardiol.
Eikelboom JW, Quinlan DJ, Hirsh J, Connolly SJ, Weitz JI
doi: 10.1001/jamacardio.
Atrial FibrillationThrombosis and Stroke
Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2)
Eur Heart J.
Birnie DH, Healey JS, Wells GA, Ayala-Paredes F, Coutu B, Sumner GL, Becker G, Verma A, Philippon F, Kalfon E, Eikelboom J, Sandhu RK, Nery PB, Lellouche N, Connolly SJ, Sapp J, Essebag V
doi: 10.1093/eurheartj/ehy413.
Atrial FibrillationTherapy and Intervention
Less dementia with oral anticoagulation in atrial fibrillation
Eur Heart J.
Friberg L, Rosenqvist M
doi: 10.1093/
Atrial FibrillationThrombosis and StrokeTherapy and Intervention
Long-term Thromboembolic Risk in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Graft Surgery and Patients With Nonvalvular Atrial Fibrillation
JAMA Cardiol.
Butt JH, Xian Y, Peterson ED, Olsen PS, Rørth R, Gundlund A, Olesen JB, Gislason GH, Torp-Pedersen C, Køber L, Fosbøl EL
doi: 10.1001/jamacardio.
Atrial Fibrillation
Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis of Observational Studies
Drug Saf.
Douros A, Durand M, Doyle CM, Yoon S, Reynier P, Filion KB
doi: 10.1007/s40264-